Literature DB >> 1560264

Dynamic stereotactic radiosurgery in the palliative treatment of cerebral metastatic tumors.

J L Caron1, L Souhami, E B Podgorsak.   

Abstract

From October 1988 to April 1990, 9 patients with metastatic brain disease (11 lesions) underwent stereotactic radiosurgery. All patients but two had recurrent metastatic disease after previous brain irradiation. The patients were treated with a single dose of 20 Gy, delivered to spherical target volumes ranging in diameters from 10 mm to 30 mm and prescribed to the 90% isodose surface. All tumors treated showed a favorable response to the treatment, with 4 patients achieving a complete radiological disappearance of the tumor. The majority of the patients experienced a rapid clinical improvement of their symptoms. No complications attributable to the radiosurgical treatment were seen. Stereotactic radiosurgery appears to be an effective and safe treatment for patients with recurrent metastatic brain disease.

Entities:  

Mesh:

Year:  1992        PMID: 1560264     DOI: 10.1007/bf00172669

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  16 in total

1.  The high-energy proton beam as a neurosurgical tool.

Authors:  B LARSSON; L LEKSELL; B REXED; P SOURANDER; W MAIR; B ANDERSSON
Journal:  Nature       Date:  1958-11-01       Impact factor: 49.962

2.  The stereotaxic method and radiosurgery of the brain.

Authors:  L LEKSELL
Journal:  Acta Chir Scand       Date:  1951-12-13

3.  Gamma knife surgery for recurrent solitary metastasis of a cerebral hypernephroma: case report.

Authors:  C Lindquist
Journal:  Neurosurgery       Date:  1989-11       Impact factor: 4.654

4.  A system for stereotactic radiosurgery with a linear accelerator.

Authors:  W Lutz; K R Winston; N Maleki
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-02       Impact factor: 7.038

5.  The treatment of recurrent brain metastases with stereotactic radiosurgery.

Authors:  J S Loeffler; H M Kooy; P Y Wen; H A Fine; C W Cheng; E G Mannarino; J S Tsai; E Alexander
Journal:  J Clin Oncol       Date:  1990-04       Impact factor: 44.544

6.  Stereotactic percutaneous single dose irradiation of brain metastases with a linear accelerator.

Authors:  V Sturm; B Kober; K H Höver; W Schlegel; R Boesecke; O Pastyr; G H Hartmann; S Schabbert; K zum Winkel; S Kunze
Journal:  Int J Radiat Oncol Biol Phys       Date:  1987-02       Impact factor: 7.038

7.  A helium-ion beam for stereotactic radiosurgery of central nervous system disorders.

Authors:  J T Lyman; L Kanstein; F Yeater; J I Fabrikant; K A Frankel
Journal:  Med Phys       Date:  1986 Sep-Oct       Impact factor: 4.071

8.  Cerebral radiation surgery using moving field irradiation at a linear accelerator facility.

Authors:  G H Hartmann; W Schlegel; V Sturm; B Kober; O Pastyr; W J Lorenz
Journal:  Int J Radiat Oncol Biol Phys       Date:  1985-06       Impact factor: 7.038

9.  Treatment for patients with cerebral metastases.

Authors:  W R Markesbery; W H Brooks; G D Gupta; A B Young
Journal:  Arch Neurol       Date:  1978-11

10.  Disposition of cerebral metastases from malignant melanoma: implications for radiosurgery.

Authors:  P Davey; P O'Brien
Journal:  Neurosurgery       Date:  1991-01       Impact factor: 4.654

View more
  3 in total

1.  Prognostic factor analysis for multiple brain metastases after gamma knife radiosurgery: results in 97 patients.

Authors:  A Schoeggl; K Kitz; A Ertl; M Reddy; G Bavinzski; B Schneider
Journal:  J Neurooncol       Date:  1999-04       Impact factor: 4.130

2.  When Should Neuroendovascular Care for Patients With Acute Stroke Be Palliative?

Authors:  Michael J Young; Robert W Regenhardt; Leonard L Sokol; Thabele M Leslie-Mazwi
Journal:  AMA J Ethics       Date:  2021-10-01

3.  The role of adjuvant radiation and multiple resection within the surgical management of brain metastases.

Authors:  F Weber; A Riedel; W Köning; J Menzel
Journal:  Neurosurg Rev       Date:  1996       Impact factor: 3.042

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.